Leflunomide-associated progressive multifocal leukoencephalopathy.

Rahmlow, Megan; Shuster, Elizabeth A; Dominik, Jacob; Deen, H Gordon; Dickson, Dennis W; Aksamit, Allen J; Robles, Hector A; Freeman, William D

Rahmlow, Megan; Shuster, Elizabeth A; Dominik, Jacob; Deen, H Gordon; Dickson, Dennis W; Aksamit, Allen J; Robles, Hector A; Freeman, William D.

Affiliation

Rahmlow M; Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA.

Arch Neurol ; 65(11): 1538-9, 2008 Nov.

Article in En | MEDLINE | ID: mdl-19001176

Subject(s)

Immunosuppressive Agents/adverse effects; Isoxazoles/adverse effects; Leukoencephalopathy, Progressive Multifocal/chemically induced; Leukoencephalopathy, Progressive Multifocal/diagnosis; Arthritis, Rheumatoid/drug therapy; Biopsy; Brain/pathology; Cytarabine/administration & dosage; Cytarabine/therapeutic use; Humans; Immunosuppressive Agents/therapeutic use; Injections, Intravenous; Isoxazoles/therapeutic use; Leflunomide; Leukoencephalopathy, Progressive Multifocal/complications; Leukoencephalopathy, Progressive Multifocal/drug therapy; Magnetic Resonance Imaging; Male; Middle Aged; Seizures/etiology; Staining and Labeling

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukoencephalopathy, Progressive Multifocal / Immunosuppressive Agents / Isoxazoles Type of study: Etiology_studies / Risk_factors_studies Limits: Humans / Male / Middle aged Language: En Journal: Arch Neurol Year: 2008 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google